Andere Sprachen Zhejiang Jolly Pharmaceutical Co.,LTD

Aktien

300181

CNE100001096

300181

Schlusskurs Shenzhen S.E. Andere Börsenplätze 00:00:00 30.04.2024			% 5 Tage	% 1. Jan.
14,91 ^CNY	+2,83 %		+4,85 %	+39,87 %

18.04.	Zhejiang Jolly Pharmaceutical Co.,LTD meldet Gewinnergebnisse für das erste Quartal bis zum 31. März 2024	CI
2023	Zhejiang Jolly Pharmaceutical Co.,LTD meldet Gewinnergebnisse für die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Zhejiang Jolly Pharmaceutical Co.,LTD announced that it has received CNY 909.999997 million in funding	19.04.
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2024	18.04.
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2023	22.10.23
Zhejiang Jolly Pharmaceutical Co.,LTD(XSEC:300181) added to S&P Global BMI Index	18.09.23
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2023	08.08.23
Zhejiang Jolly Pharmaceutical Co.,LTD Announces Cash Dividend on A Shares for the Year 2022, Payable on 30 May 2023	24.05.23
Zhejiang Jolly Pharmaceutical Co.,LTD Approves Cash Dividend for 2022	22.05.23
Zhejiang Jolly Pharmaceutical Co.,LTD Proposes Final Cash Dividend for the Year 2022	26.04.23
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2023	25.04.23
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Nine Months Ended September 30, 2022	24.10.22
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Half Year Ended June 30, 2022	29.08.22
Zhejiang Jolly Pharmaceutical Co.,LTD signed an equity transfer agreement to acquire the remaining 48.99% stake in Zhejiang Jolly Baicao Chinese Medicine Decoction Pieces Co., Ltd. from Chen Huan and Chen Zhaorong for RMB 75 million.	15.08.22
Zhejiang Jolly Pharmaceutical Co.,LTD Announces Final Profit Distribution Plan to Be Implemented on A Shares for the Year 2021, Payable on 31 May 2022	25.05.22
Zhejiang Jolly Pharmaceutical Co.,LTD completed the acquisition of 8% stake in Zhejiang Top Medicine Co.,Ltd. from Yu Yin.	17.05.22
Zhejiang Jolly Pharmaceutical Co.,Ltd Approves Cash Dividend for 2021	13.05.22
Zhejiang Jolly Pharmaceutical Co.,LTD Proposes Cash Dividend for 2021	20.04.22
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the First Quarter Ended March 31, 2022	19.04.22
Zhejiang Jolly Pharmaceutical Co.,LTD Reports Earnings Results for the Full Year Ended December 31, 2021	09.03.22
Zhejiang Jolly Pharmaceutical Co.,LTD announced that it expects to receive CNY 910 million in funding	26.01.22
Zhejiang Jolly Pharmaceutical Co.,LTD agreed to acquire 8% stake in Zhejiang Top Medicine Co.,Ltd. from Yu Yin for CNY 10.7 million.	28.12.21

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Zhejiang Jolly Pharmaceutical Co.,LTD

Aktien

300181

CNE100001096

300181

Andere Sprachen

Filter